Clinical Trial Update: Cinacalcet to Treat Familial Primary Hyperparathyroidism [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cinacalcet for familial primary hyperparathyroidism with hypercalcemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Primary Hyperparathyroidism
• Hypercalcemia

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hypercalcemia, Familial Primary Hyperparathyroidism | Phase 3 | Status: COMPLETED